May 27, 2025 | Health Care, Health Care Fraud
Dr. Jorge Zamora-Quezada, a rheumatologist from Mission, Texas, has been sentenced to 10 years in federal prison and three years of supervised release for orchestrating a massive health care fraud scheme involving more than $118 million in false claims. Dr....
May 19, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud
On May 16, 2025, the United States Attorney’s Office for the Middle District of Florida announced that it had reached a False Claims Act (FCA) settlement with Florida-based ophthalmology practice Gulfcoast Eye Care. The government alleged that Gulfcoast...
May 19, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud
On May 16, the United States Attorney’s Office for the Western District of New York announced that Buffalo-based Catholic Health System (CHS) agreed to pay $3.3 million to resolve allegations that it violated the False Claims Act (FCA). According to local news...
May 11, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud
On May 9, 2025, the United States Department of Justice (DOJ) announced that pharmaceutical manufacturer Assertio Therapeutics had agreed to pay $3.6 million to resolve allegations that it violated the False Claims Act (FCA) by causing the submission of false claims...
May 8, 2025 | False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Earlier this year, Chilivis Grubman founding partner Scott Grubman wrote an article for the Georgia State Bar Health Law Section’s Newsletter, wherein he discussed the continued fight over the constitutionality of the False Claims Act’s (FCA) qui tam (or...
Apr 30, 2025 | False Claims Act, Health Care, Health Care Fraud
On April 29, 2025, the U.S. Department of Justice (United States Attorney’s Office, Southern District of New York) announced that pharmaceutical giant Gilead Sciences agreed to pay a whopping $202 Million to resolve a False Claims Act investigation. At issue...
